These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 37143154

  • 1. Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced: the PUMA trial.
    Regnery S, de Colle C, Eze C, Corradini S, Thieke C, Sedlaczek O, Schlemmer HP, Dinkel J, Seith F, Kopp-Schneider A, Gillmann C, Renkamp CK, Landry G, Thorwarth D, Zips D, Belka C, Jäkel O, Debus J, Hörner-Rieber J.
    Radiat Oncol; 2023 May 04; 18(1):74. PubMed ID: 37143154
    [Abstract] [Full Text] [Related]

  • 2. Treating locally advanced lung cancer with a 1.5T MR-Linac - Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy.
    Bainbridge HE, Menten MJ, Fast MF, Nill S, Oelfke U, McDonald F.
    Radiother Oncol; 2017 Nov 04; 125(2):280-285. PubMed ID: 28987747
    [Abstract] [Full Text] [Related]

  • 3. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
    Hoegen P, Zhang KS, Tonndorf-Martini E, Weykamp F, Regnery S, Naumann P, Lang K, Ristau J, Körber SA, Dreher C, Buchele C, Rippke C, Renkamp CK, Paul KM, König L, Büsch C, Krisam J, Sedlaczek O, Schlemmer HP, Niyazi M, Corradini S, Debus J, Klüter S, Hörner-Rieber J.
    Radiat Oncol; 2022 Mar 27; 17(1):59. PubMed ID: 35346270
    [Abstract] [Full Text] [Related]

  • 4. Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3).
    Regnery S, Ristau J, Weykamp F, Hoegen P, Sprengel SD, Paul KM, Buchele C, Klüter S, Rippke C, Renkamp CK, Pohl M, Meis J, Welzel T, Adeberg S, Koerber SA, Debus J, Hörner-Rieber J.
    Radiat Oncol; 2022 May 25; 17(1):102. PubMed ID: 35614486
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A daily end-to-end quality assurance workflow for MR-guided online adaptive radiation therapy on MR-Linac.
    Chen X, Ahunbay E, Paulson ES, Chen G, Li XA.
    J Appl Clin Med Phys; 2020 Jan 25; 21(1):205-212. PubMed ID: 31799753
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synthetic 4D-CT of the thorax for treatment plan adaptation on MR-guided radiotherapy systems.
    Freedman JN, Bainbridge HE, Nill S, Collins DJ, Kachelrieß M, Leach MO, McDonald F, Oelfke U, Wetscherek A.
    Phys Med Biol; 2019 May 23; 64(11):115005. PubMed ID: 30844775
    [Abstract] [Full Text] [Related]

  • 14. MR-guidance--a clinical study to evaluate a shuttle- based MR-linac connection to provide MR-guided radiotherapy.
    Bostel T, Nicolay NH, Grossmann JG, Mohr A, Delorme S, Echner G, Häring P, Debus J, Sterzing F.
    Radiat Oncol; 2014 Jan 09; 9():12. PubMed ID: 24401489
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cone-beam CT-guided radiotherapy in the management of lung cancer: Diagnostic and therapeutic value.
    Elsayad K, Kriz J, Reinartz G, Scobioala S, Ernst I, Haverkamp U, Eich HT.
    Strahlenther Onkol; 2016 Feb 09; 192(2):83-91. PubMed ID: 26630946
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Accelerated hypofractionated magnetic resonance-guided adaptive radiotherapy for oligoprogressive non-small cell lung cancer.
    La Rosa A, Mittauer KE, Chuong MD, Hall MD, Kutuk T, Bassiri N, McCulloch J, Alvarez D, Herrera R, Gutierrez AN, Tolakanahalli R, Mehta MP, Kotecha R.
    Med Dosim; 2016 Feb 09; 48(4):238-244. PubMed ID: 37330328
    [Abstract] [Full Text] [Related]

  • 19. Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer.
    Schaule J, Chamberlain M, Wilke L, Baumgartl M, Krayenbühl J, Zamburlini M, Mayinger M, Andratschke N, Tanadini-Lang S, Guckenberger M.
    Radiat Oncol; 2021 Sep 26; 16(1):189. PubMed ID: 34565439
    [Abstract] [Full Text] [Related]

  • 20. Local control and toxicity after magnetic resonance imaging (MR)-guided single fraction lung stereotactic ablative radiotherapy.
    Tekatli H, Palacios MA, Schneiders FL, Haasbeek CJA, Slotman BJ, Lagerwaard FJ, Senan S.
    Radiother Oncol; 2023 Oct 26; 187():109823. PubMed ID: 37516364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.